Drug record
What four public record sets show for topiramate. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.027 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $130.1 million | Details |
| FDA recall records | 11 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Topiramate 25 Mg Tablet: pharmacies pay about $0.027 each, or $0.817 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| TOPIRAMATE 100 MG TABLET | Generic | $0.059 per each | $1.78 | Oct 21, 2026 |
| TOPIRAMATE 15 MG SPRINKLE CAP | Generic | $0.231 per each | $6.94 | Oct 21, 2026 |
| TOPIRAMATE 200 MG TABLET | Generic | $0.109 per each | $3.27 | Oct 21, 2026 |
| TOPIRAMATE 25 MG SPRINKLE CAP | Generic | $0.245 per each | $7.34 | Oct 21, 2026 |
| TOPIRAMATE 25 MG TABLET | Generic | $0.027 per each | $0.817 | Oct 21, 2026 |
| TOPIRAMATE 25 MG/ML SOLUTION | Generic | $1.08 per mL | — | Oct 21, 2026 |
| TOPIRAMATE 50 MG SPRINKLE CAP | Generic | $4.29 per each | $128.83 | Oct 21, 2026 |
| TOPIRAMATE 50 MG TABLET | Generic | $0.040 per each | $1.19 | Oct 21, 2026 |
| TOPIRAMATE ER 100 MG CAPSULE | Generic | $9.10 per each | $273.14 | Oct 21, 2026 |
| TOPIRAMATE ER 100 MG SPRINK CAP | Generic | $5.78 per each | $173.33 | Oct 21, 2026 |
| TOPIRAMATE ER 150 MG SPRINK CAP | Generic | $7.03 per each | $210.96 | Oct 21, 2026 |
| TOPIRAMATE ER 200 MG CAPSULE | Generic | $17.41 per each | $522.39 | Oct 21, 2026 |
| TOPIRAMATE ER 200 MG SPRINK CAP | Generic | $9.89 per each | $296.69 | Oct 21, 2026 |
| TOPIRAMATE ER 25 MG CAPSULE | Generic | $3.66 per each | $109.79 | Oct 21, 2026 |
| TOPIRAMATE ER 25 MG SPRINKL CAP | Generic | $2.23 per each | $66.90 | Oct 21, 2026 |
| TOPIRAMATE ER 50 MG CAPSULE | Generic | $5.67 per each | $170.25 | Oct 21, 2026 |
| TOPIRAMATE ER 50 MG SPRINKL CAP | Generic | $3.24 per each | $97.12 | Oct 21, 2026 |
| EPRONTIA 25 MG/ML SOLUTION | Brand | $1.58 per mL | — | Oct 21, 2026 |
| TOPAMAX 100 MG TABLET | Brand | $17.92 per each | $537.65 | Oct 21, 2026 |
| TOPAMAX 200 MG TABLET | Brand | $21.07 per each | $632.05 | Oct 21, 2026 |
| TOPAMAX 25 MG SPRINKLE CAP | Brand | $7.54 per each | $226.20 | Oct 21, 2026 |
| TOPAMAX 25 MG TABLET | Brand | $6.58 per each | $197.33 | Oct 21, 2026 |
| TOPAMAX 50 MG TABLET | Brand | $13.13 per each | $393.80 | Oct 21, 2026 |
| TROKENDI XR 100 MG CAPSULE | Brand | $34.44 per each | $1,033.13 | Jul 1, 2026 |
| TROKENDI XR 200 MG CAPSULE | Brand | $47.14 per each | $1,414.29 | Jul 1, 2026 |
| TROKENDI XR 25 MG CAPSULE | Brand | $13.30 per each | $398.98 | Jul 1, 2026 |
| TROKENDI XR 50 MG CAPSULE | Brand | $17.43 per each | $523.00 | Jul 1, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $130.1 million for the 6 products below. That is down 28% from $180.7 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Topamax Topiramate | $41.4 million | 3,052 | $1,922.19 | $13,558.59 | $53.0 million |
| Topiramate Topiramate | $40.4 million | 691,304 | $12.24 | $58.51 | $55.8 million |
| Topiramate ER Topiramate | $28.2 million | 6,949 | $796.63 | $4,063.41 | $10.9 million |
| Trokendi XR Topiramate | $17.9 million | 1,471 | $1,837.47 | $12,185.29 | $57.6 million |
| Qudexy XR Topiramate | $1.2 million | 106 | $1,818.96 | $11,205.50 | $3.4 million |
| Eprontia Topiramate | $895,691 | 235 | $656.66 | $3,811.45 | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 11 recall records that name topiramate in the product description (5 Class II · 6 Class III). 2 are still marked ongoing.
Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.
Reason: Failed dissolution specifications.
Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.
Reason: Failed Dissolution Specifications
Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1
Reason: Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.
Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Area. Meerut Road, Ghaziabad -201 003, India. Manufactured for: Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ 06815, NDC 29300-116-05.
Reason: Discoloration
Trokendi XR (topiramate) extended-release capsules 100 mg 30 Capsules Rx only, Manufactured by: Catalent Pharma Solutions Winchester, KY 40391 USA Manufactured for: Supernus Pharmaceuticals, Inc. Rockville, MD 20850 USA, NDC 17772-103-30
Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Topiramate 25mg Tabs White/round tablets, 10-count bags, Distributed by: Calvin Scott & Co., Inc. Alb., MN 87123, Mfg: Sun Pharm., Inc. Cranbury, NJ 08512, NDC 47335-0707-13
Reason: CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850, NDC 17772-102-15
Reason: Superpotent Drug: Failure of assay specifications in the capsule.
Topiramate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Reason: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles, Rx Only. Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ USA 08534. NDC 68382-141-14.
Reason: Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.
Glenmark Topiramate Tablets, 200 mg, 60-count bottle, (NDC 68462-110-60), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India Manufactured for : Glenmark Generics USA Mahwah, NJ 07430
Reason: Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.
Topiramate Tablets, 50 mg, 30-count (3 x 10) unit-dose blisters per carton, Rx only, Mfd by: Cadila Healthcare Ltd., Ahmedabad, India; Dist By: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, Pkg by: American Health Packaging, Col. OH 43217, NDC 68084-343-21, blister barcode 6808434311
Reason: Labeling: Label Mix-Up: A typographical error in the product form on the carton label incorrectly lists the configuration as 30 "Capsules" (3 x 10) rather than "Tablets".
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for topiramate. This page is public-record information, not medical advice.